参考文献:1个药物宣传。世界卫生组织。2015。可从:http://www.who.int/medicines/areas/quality_safety/safety_e-ceracy/pharmvigi/en/2。风险管理。欧洲药品局。https://www.ema.europa.eu/en/human-regulatory/marketing-authorisation/pharmacovigilance/risk-management 3 Morimoto T,Gandhi TK,Seger tk,Seger AC,AC,HSIEH TC,BATES DC,BATES DW。不良药物事件和药物错误:检测和分类方法。Qual Saf Health Care 2004; 13:306–314。可从:https://qualitysafety.bmj.com/content/13/4/306 4. https://health.gov/our-work/work/work/health-care-quare-quality/ardverse-drug-events#1 5。日记哨兵。分析:药物副作用的报道在12年内增加了五个。可从:https://www.jsonline.com/story/news/investigations/2017/03/17/analsiss-reports-reports-drug-side-eects-see-see-major-see-major-increase/99211376/。6。fda。,FDA专员Scott Gottlieb,M.D。的声明,就管理要求提供新的FDA资金,以促进创新并通过竞争扩大患者访问权限。可用
主要关键词